Solidarity Wealth’s AbbVie ABBV Stock Holding History

Solidarity Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$941K	Buy	3,739 +49	+1%	+$10.5K	0.16%	52
2026 Q1	$803K	Hold	3,690	–	–	0.15%	51
2025 Q4	$843K	Sell	3,690 -214	-5%	-$48.7K	0.17%	44
2025 Q3	$904K	Buy	3,904 +187	+5%	+$38.1K	0.19%	49
2025 Q2	$690K	Hold	3,717	–	–	0.16%	51
2025 Q1	$779K	Buy	3,717 +18	+0.5%	+$3.5K	0.19%	57
2024 Q4	$657K	Sell	3,699 -724	-16%	-$133K	0.17%	56
2024 Q3	$873K	Sell	4,423 -825	-16%	-$154K	0.24%	50
2024 Q2	$900K	Sell	5,248 -302	-5%	-$50K	0.27%	53
2024 Q1	$1.01M	Sell	5,550 -98	-2%	-$16.9K	0.32%	48
2023 Q4	$875K	Sell	5,648 -1,092	-16%	-$159K	0.32%	47
2023 Q3	$1M	Sell	6,740 -108	-2%	-$15.9K	0.36%	48
2023 Q2	$923K	Sell	6,848 -31	-0.5%	-$4.55K	0.38%	45
2023 Q1	$1.1M	Buy	+6,879	New	+$1.05M	0.5%	46
2022 Q3	$1.03M	Buy	6,975 +260	+4%	+$37.3K	0.6%	42
2022 Q2	$964K	Buy	6,715 +984	+17%	+$150K	0.52%	45
2022 Q1	$896K	Buy	+5,731	New	+$832K	0.5%	42

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Solidarity Wealth's ABBV Position: Q2 2026 in Review

Solidarity Wealth increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $10.5K and bringing the position to 3,739 shares worth $941K. The position accounts for 0.16% of the portfolio, ranked #52.

Solidarity Wealth first reported a position in ABBV in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.1M in Q1 2023. 2,132 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Solidarity Wealth held 3,739 shares of AbbVie worth $941K as of Q2 2026.
Solidarity Wealth bought 49 AbbVie shares in Q2 2026, an estimated $10.5K.
AbbVie made up 0.16% of Solidarity Wealth's portfolio in Q2 2026, its #52 holding.
Solidarity Wealth first reported a position in AbbVie in Q1 2022 and has held it in 17 quarters since.
Solidarity Wealth's AbbVie position peaked at $1.1M in Q1 2023.
2,132 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Solidarity Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.